Shopping Cart
Remove All
Your shopping cart is currently empty
DFRF4539A (RG-7598) is an ADC (antibody-drug conjugate) containing the antimitotic agent MMAE and a humanised antibody targeting FcRH5/CD307e (MFRF3266A), linked via a protease-unstable MC-VC-PABC linker, for use in relapsed/refractory multiple myeloma.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $745 | - | In Stock | |
| 10 mg | $1,180 | - | In Stock | |
| 25 mg | $1,770 | - | In Stock | |
| 50 mg | $2,380 | - | In Stock |
| Description | DFRF4539A (RG-7598) is an ADC (antibody-drug conjugate) containing the antimitotic agent MMAE and a humanised antibody targeting FcRH5/CD307e (MFRF3266A), linked via a protease-unstable MC-VC-PABC linker, for use in relapsed/refractory multiple myeloma. |
| Synonyms | RG-7598 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.